Competition & antitrust

August 2024  |  SPECIAL REPORT: COMPETITION & ANTITRUST

Financier Worldwide Magazine

August 2024 Issue


Q&A: Antitrust challenges in the pharmaceutical industry

The effective enforcement of antitrust law is increasingly important in delivering access to a wider choice of affordable and innovative medicines. The competition law rules play a role in safeguarding the competitive process and consumer welfare at every stage of the market, from product development to product launch and lifecycle management. FW discusses antitrust challenges in the pharmaceutical industry with Sebastian Dworschak at Hengeler Mueller, May Lyn Yuen at Hogan Lovells and Kate McNeece at McCarthy Tétrault.

Algorithmic pricing under the antitrust microscope: lessons from recent developments

Skadden, Arps, Slate, Meagher & Flom LLP and Affiliates Given the flurry of activity from civil plaintiffs and posturing from government enforcers, companies should nevertheless take care to assess their use of algorithmic pricing technology and, where business considerations permit, can take steps to reduce potential risks.

Generational changes to Canada’s competition law framework

Burnet, Duckworth & Palmer LLP Greater financial penalties, more active enforcement by the commissioner, as well as increased rights of enforcement by private entities will require Canadian businesses to pay much closer attention to the laws that govern competition in Canada.

CMA’s increased powers in UK competition law investigations

Gowling WLG (UK) LLP The UK’s Competition and Markets Authority is committed to taking action against anti-competitive conduct, and its ability to do so will be enhanced by the Digital Markets, Competition and Consumers Act.

The shifting boundaries of competition law in Europe

Gleiss Lutz Hootz Hirsch PartmbB From the post-war decartelisation to the recent wave of digital regulation, legislators, competition authorities and courts have had to adapt to changing economic realities and public interests.

Belgium ends merger control in the hospital sector

CMS Belgium As the Belgian legislator intended, the BCA’s authority to review hospital concentrations has now been diminished to nearly the fullest extent of its capacity. Its competence remains only in very specific circumstances.

Japan’s challenge to encourage competition in the smartphone software market

Mori Hamada & Matsumoto In Japan, the Japan Fair Trade Commission and other government agencies are trying to find the best solutions to introduce a strong framework of regulations and policies. This May, new legislation was enacted, which could be a turning point.


CONTRIBUTORS

Burnet, Duckworth & Palmer LLP

CMS Belgium

Gleiss Lutz Hootz Hirsch PartmbB

Gowling WLG (UK) LLP

Hengeler Mueller

Hogan Lovells

McCarthy Tétrault

Mori Hamada & Matsumoto

Skadden, Arps, Slate, Meagher & Flom LLP and Affiliates


©2001-2024 Financier Worldwide Ltd. All rights reserved. Any statements expressed on this website are understood to be general opinions and should not be relied upon as legal, financial or any other form of professional advice. Opinions expressed do not necessarily represent the views of the authors’ current or previous employers, or clients. The publisher, authors and authors' firms are not responsible for any loss third parties may suffer in connection with information or materials presented on this website, or use of any such information or materials by any third parties.